• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价:破坏性胃食管反流病对健康相关生活质量的负担。

Systematic review: the burden of disruptive gastro-oesophageal reflux disease on health-related quality of life.

机构信息

Centre for Gastroenterological Research and Division of Gastroenterology, University Hospital Gasthuisberg, Catholic University Leuven, Belgium.

出版信息

Aliment Pharmacol Ther. 2012 Jun;35(11):1257-66. doi: 10.1111/j.1365-2036.2012.05086.x. Epub 2012 Apr 8.

DOI:10.1111/j.1365-2036.2012.05086.x
PMID:22486579
Abstract

BACKGROUND

About one-third of patients with gastro-oesophageal reflux disease (GERD) have frequent and/or severe reflux symptoms ('disruptive GERD'). The relative burden of disruptive GERD on health-related quality of life (HRQL) has not been systematically investigated.

AIM

To assess the burden of disruptive vs. nondisruptive GERD on HRQL.

METHODS

Systematic searches were conducted in PubMed and Embase. To be included, studies had to have used validated questionnaires to assess HRQL.

RESULTS

Nineteen studies were included. Data on the comparative burden of frequent (ranging from daily to ≥weekly) and severe reflux symptoms were provided in eight and 13 studies respectively; six reported on the additional burden of nocturnal symptoms. Compared with individuals with nondisruptive GERD, those with disruptive GERD had 2.4-times and 1.5-times higher mean rates of absenteeism and presenteeism respectively (five studies), 1.5-times lower sleep quality scores (three studies), 1.1-times lower mean summary scores for physical and mental health (five studies) and 1.3-times lower mean scores for psychological and general well-being (four studies). Increasing symptom frequency and severity both increased the burden of disease to a similar extent. The presence of nocturnal symptoms in addition to daytime symptoms led to worsening of physical health, but their effect on mental health and work productivity was less clear.

CONCLUSIONS

Disruptive GERD is associated with a high burden of disease compared with occasional or mild reflux symptoms. Disease management needs to vary across the GERD spectrum and should be tailored to patients' requirements for optimal therapeutic outcomes.

摘要

背景

约三分之一的胃食管反流病(GERD)患者存在频繁和/或严重的反流症状(“破坏性 GERD”)。破坏性 GERD 对健康相关生活质量(HRQL)的相对负担尚未系统研究。

目的

评估破坏性与非破坏性 GERD 对 HRQL 的负担。

方法

系统检索了 PubMed 和 Embase。纳入的研究必须使用经过验证的问卷来评估 HRQL。

结果

纳入了 19 项研究。有 8 项研究提供了关于频繁(每天至每周≥一次)和严重反流症状的比较负担数据,13 项研究报告了夜间症状的额外负担。与非破坏性 GERD 患者相比,破坏性 GERD 患者的缺勤率分别高出 2.4 倍和 1.5 倍(5 项研究),睡眠质量评分低 1.5 倍(3 项研究),身体和心理健康综合评分低 1.1 倍(5 项研究),心理和一般健康状况评分低 1.3 倍(4 项研究)。症状频率和严重程度的增加都会导致疾病负担的增加。除日间症状外,夜间症状的存在会导致身体健康恶化,但对心理健康和工作效率的影响不太明确。

结论

与偶尔或轻度反流症状相比,破坏性 GERD 与更高的疾病负担相关。疾病管理需要根据 GERD 谱的不同而有所变化,并应根据患者的需求进行调整,以获得最佳的治疗效果。

相似文献

1
Systematic review: the burden of disruptive gastro-oesophageal reflux disease on health-related quality of life.系统评价:破坏性胃食管反流病对健康相关生活质量的负担。
Aliment Pharmacol Ther. 2012 Jun;35(11):1257-66. doi: 10.1111/j.1365-2036.2012.05086.x. Epub 2012 Apr 8.
2
Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.系统评价:质子泵抑制剂对胃食管反流病患者症状缓解与健康相关生活质量的相关性。
Aliment Pharmacol Ther. 2011 Sep;34(6):618-27. doi: 10.1111/j.1365-2036.2011.04774.x. Epub 2011 Jul 20.
3
The clinical characteristics and impact of laryngopharyngeal reflux disease on health-related quality of life.喉咽反流疾病的临床特征及其对健康相关生活质量的影响。
Value Health. 2003 Sep-Oct;6(5):560-5. doi: 10.1046/j.1524-4733.2003.65243.x.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Pharmacological treatment of gastro-oesophageal reflux in children.儿童胃食管反流病的药物治疗。
Cochrane Database Syst Rev. 2023 Aug 22;8(8):CD008550. doi: 10.1002/14651858.CD008550.pub3.
6
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Cisapride treatment for gastro-oesophageal reflux in children.西沙必利治疗儿童胃食管反流
Cochrane Database Syst Rev. 2002(3):CD002300. doi: 10.1002/14651858.CD002300.
9
Systematic review: health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease.系统评价:胃食管反流病的健康相关生活质量(HRQOL)问卷
Aliment Pharmacol Ther. 2008 Jun 1;27(11):1053-70. doi: 10.1111/j.1365-2036.2008.03683.x. Epub 2008 Mar 20.
10
Cisapride treatment for gastro-oesophageal reflux in children.西沙必利治疗儿童胃食管反流
Cochrane Database Syst Rev. 2003(4):CD002300. doi: 10.1002/14651858.CD002300.

引用本文的文献

1
Association between an energy-adjusted inflammatory diet index and gastroesophageal reflux disease: a retrospective cohort study.能量调整后的炎症性饮食指数与胃食管反流病之间的关联:一项回顾性队列研究。
Eur J Nutr. 2025 Apr 16;64(4):154. doi: 10.1007/s00394-025-03678-x.
2
Pre-frailty is associated with higher risk of gastroesophageal reflux disease: a large prospective cohort study.衰弱前期与胃食管反流病的较高风险相关:一项大型前瞻性队列研究。
Sci Rep. 2025 Mar 14;15(1):8916. doi: 10.1038/s41598-025-93114-1.
3
Correlation of gastro-esophageal reflux disease with asthma control and quality of life: a cross-sectional study from a low-middle income country.
胃食管反流病与哮喘控制和生活质量的相关性:来自中低收入国家的横断面研究。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241297879. doi: 10.1177/17534666241297879.
4
The Cost Effectiveness of Adjunctive Treatments for Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.质子泵抑制剂难治性胃食管反流病辅助治疗的成本效果分析。
Clin Drug Investig. 2024 Sep;44(9):703-714. doi: 10.1007/s40261-024-01387-7. Epub 2024 Sep 7.
5
The Economic Impact of Introducing RefluxStop for Refractory Gastroesophageal Reflux Disease on the Italian Healthcare System.引入RefluxStop治疗难治性胃食管反流病对意大利医疗保健系统的经济影响。
Pharmacoecon Open. 2024 Nov;8(6):935-943. doi: 10.1007/s41669-024-00521-7. Epub 2024 Aug 27.
6
Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia.评估经口内镜肌切开术治疗贲门失弛缓症疗效的新量表。
J Gastroenterol. 2024 Aug;59(8):658-667. doi: 10.1007/s00535-024-02119-6. Epub 2024 May 30.
7
Impact of Age on Long-Term Outcomes of Laparoscopic Nissen Fundoplication-A Single Center Study.年龄对腹腔镜 Nissen 胃底折叠术长期疗效的影响:单中心研究。
Medicina (Kaunas). 2024 Apr 24;60(5):688. doi: 10.3390/medicina60050688.
8
Personalized anti-reflux surgery: connecting GERD phenotypes in 690 patients to outcomes.个体化抗反流手术:将 690 例患者的 GERD 表型与结果联系起来。
Surg Endosc. 2024 Jun;38(6):3273-3278. doi: 10.1007/s00464-024-10756-4. Epub 2024 Apr 24.
9
Microbiota profiling in esophageal diseases: Novel insights into molecular staining and clinical outcomes.食管疾病中的微生物群分析:分子染色与临床结果的新见解。
Comput Struct Biotechnol J. 2023 Dec 27;23:626-637. doi: 10.1016/j.csbj.2023.12.026. eCollection 2024 Dec.
10
Budget Impact of RefluxStop™ as a Treatment for Patients with Refractory Gastro-oesophageal Reflux Disease in the United Kingdom.RefluxStop™作为英国难治性胃食管反流病患者治疗方法的预算影响
J Health Econ Outcomes Res. 2024 Jan 11;11(1):1-7. doi: 10.36469/001c.90924. eCollection 2024.